VERO vs. IONM, AVGR, AEMD, GMVDF, STSS, INVO, TNON, NMRD, RSLS, and DYNT
Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Assure (IONM), Avinger (AVGR), Aethlon Medical (AEMD), G Medical Innovations (GMVDF), Sharps Technology (STSS), INVO Bioscience (INVO), Tenon Medical (TNON), Nemaura Medical (NMRD), ReShape Lifesciences (RSLS), and Dynatronics (DYNT). These companies are all part of the "surgical & medical instruments" industry.
Venus Concept (NASDAQ:VERO) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.
Venus Concept has a net margin of -43.69% compared to Assure's net margin of -400.68%. Venus Concept's return on equity of -1,279.43% beat Assure's return on equity.
Assure has lower revenue, but higher earnings than Venus Concept.
Venus Concept has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Assure has a beta of 1.87, indicating that its stock price is 87% more volatile than the S&P 500.
87.4% of Venus Concept shares are held by institutional investors. Comparatively, 3.3% of Assure shares are held by institutional investors. 51.4% of Venus Concept shares are held by insiders. Comparatively, 1.6% of Assure shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Venus Concept received 31 more outperform votes than Assure when rated by MarketBeat users. Likewise, 65.38% of users gave Venus Concept an outperform vote while only 27.27% of users gave Assure an outperform vote.
Venus Concept currently has a consensus target price of $0.00, suggesting a potential downside of 100.00%. Assure has a consensus target price of $8.00, suggesting a potential upside of 1,584.57%. Given Assure's stronger consensus rating and higher possible upside, analysts plainly believe Assure is more favorable than Venus Concept.
In the previous week, Venus Concept had 2 more articles in the media than Assure. MarketBeat recorded 5 mentions for Venus Concept and 3 mentions for Assure. Venus Concept's average media sentiment score of 0.68 beat Assure's score of 0.45 indicating that Venus Concept is being referred to more favorably in the media.
Summary
Venus Concept beats Assure on 10 of the 16 factors compared between the two stocks.
Get Venus Concept News Delivered to You Automatically
Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Venus Concept Competitors List
Related Companies and Tools